A judge ruled that Actives Laboratories' generic version of Zohydro ER infringed on patents held by Pernix Therapeutics Holdings Inc. (Nasdaq: PTX) sending the stock price up 53 cents to close at $3.28.
Judge sides with Pernix Therapeutics
February 23, 2017 at 16:05 PM EST
